Current thought on treating chronic lymphocytic leukemia
An overview of iwCLL 2017 meeting in New York by Prof. Michael Hallek
How to explain the 'watch-and-wait' period to a CLL patient?
Era of personalized therapy in CLL
Discussion of a Phase III trial evaluating the efficacy and safety of idelalisib